Notification of Major Holdings
1. Details of issuer
STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
|
2. Reason for notification
| X |
Acquisition/disposal of shares with voting rights |
| |
Acquisition/disposal of instruments |
| |
Change of breakdown of voting rights |
| |
Other reason:
|
3. Details of person subject to the notification obligation
| Name: |
City and country of registered office: |
|
OppenheimerFunds, Inc.
|
Denver, Colorado
United States of America (USA)
|
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
Oppenheimer International Small-Mid Company Fund
|
5. Date on which threshold was crossed or reached
6. Total positions
| |
% of voting rights attached to shares
(total of 7.a.) |
% of voting rights through instruments
(total of 7.b.1 + 7.b.2) |
total of both in %
(7.a. + 7.b.) |
total number of voting rights of issuer |
| Resulting situation |
5.19 % |
0.00 % |
5.19 % |
11860995 |
| Previous notification |
3.01 % |
n/a % |
n/a % |
/ |
7. Notified details of the resulting situation
a. Voting rights attached to shares (Sec.s 21, 22 WpHG)
| ISIN |
absolute |
in % |
| |
direct
(Sec. 21 WpHG) |
indirect
(Sec. 22 WpHG) |
direct
(Sec. 21 WpHG) |
indirect
(Sec. 22 WpHG) |
| DE000STRA555 |
0 |
615133 |
0.00 % |
5.19 % |
| Total |
615133 |
5.19 % |
b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG
| Type of instrument |
Expiration or maturity date |
Exercise or conversion period |
Voting rights absolute |
Voting rights in % |
|
|
|
|
% |
| |
|
Total |
|
% |
b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG
| Type of instrument |
Expiration or maturity date |
Exercise or conversion period |
Cash or physical settlement |
Voting rights absolute |
Voting rights in % |
|
|
|
|
|
% |
| |
|
|
Total |
|
% |
8. Information in relation to the person subject to the notification obligation
| X |
Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). |
| |
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: |
| Name |
% of voting rights (if at least held 3% or more) |
% of voting rights through instruments (if at least held 5% or more) |
Total of both (if at least held 5% or more) |
| |
|
|
|
9. In case of proxy voting according to Sec. 22 para. 3 WpHG
| Date of general meeting: |
|
| Holding position after general meeting: |
% (equals voting rights) |
10. Other explanatory remarks:
| The total number of voting rights of the issuer indicated in Sec. 6 above is the number which has been published by the issuer pursuant to Sec. 26a para. 2 WpHG on 30.11.2016. The total number of voting rights of the issuer as published by the issuer pursuant to Sec. 26a para. 2 WpHG on 31.08.2016 was 11859120 voting rights which would lead to the same percentage of voting rights attached to shares (5.19%). |
